The Food and Drug Administration (FDA) is issuing a policy statement on foods derived from new plant varieties. including plants developed by recombinant deoxyribonucleic acid [DNA] techniques. This policy statement is a clarification of FDA's interpretation of the Federal Food. Drug. and Cosmetic Act (the act). with respect to new technologies to produce foods, and reflects FDA's current judgment based on new plant varieties now under development in agricultural research. I-his action is being taken to ensure that relevant scientific. safety. and regulatory issues are resolved prior to the introduction of such products into the marketplace.